3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: January 4, 2022
Period of Report: January 3, 2022
Accession Number: 0001127602-22-000682

View Document ↗ View on SEC.gov ↗